Healthcare -
Biotechnology - NASDAQ - US
$ 5.33
0.947 %
$ 237 M
Market Cap
-1.7
P/E
Price Target
Average
68.86%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
--28.53%
Net Income
Estimate
31.67%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Verastem, Inc.
Wall Street analysts predict an average 1-year price target for VSTM of $9 , with forecasts ranging from
a
low of
$5 to a high of $13 .
VSTM Lowest Price Target
Wall Street Target
5 USD
-6.19%
VSTM Average Price Target
Wall Street Target
9 USD
68.86%
VSTM Highest Price Target
Wall Street Target
13 USD
143.90%
REVENUE FORECAST
Revenue Forecast Chart VSTM
EBIT FORECAST
EBIT Forecast Chart VSTM
NET INCOME FORECAST
Net Income Chart VSTM